Flu

During flu season, a sore throat can signal another illness—Here is how to tell the difference.

The 21-week 2018-2019 influenza season was the longest in 10 years.

Baloxavir marboxil (Xofluza, Genentech) is a first in class antiviral flu treatment and is indicated in the United States for patients age 12 years and older who have been symptomatic for no more than 48 hours.

After a flu season that the CDC called one of the deadliest in recent memory, any information that can help clinicians avert patient morbidity and mortality is welcome.

With allergy symptoms still lingering and summer just around the corner, the list of top-recommended over-the-counter products helps consumers and their families stay healthy during any getaway.

The influenza vaccine for the 2019-2020 flu season will look different than it has for the past few seasons.

Top news of the day from across the health care landscape.

Being knowledgeable about the guidelines and risk factors for patients is important to ensure that they get the proper counseling on immunizations.

Pharmacy Times Continuing Education is hosting an education session at the APhA Annual Meeting & Exposition in Seattle, Washington, on this topic.

In the March 15, 2019 FluView update, the CDC reported a slight decrease in the percentage of respiratory specimens testing positive for influenza viruses in clinical laboratories, from the previous week.

The agency urges the public to receive a vaccine if they have not already done so.

The research centers on CD8+ T cells, which can recognize and attack the influenza virus.

Why is this patient requesting the flu vaccine in the middle of June?

In the week ending Feb. 16, influenza was reported as widespread in 48 states and in Puerto Rico.

Study findings also suggest a path forward to create even more effective flu vaccines.

Top news of the day across the health care landscape.

The flu vaccine prevented 7.1 million illnesses, according to the analysis, along with 109,000 hospitalizations, and 8000 deaths, during the 2017-2018 influenza season.

Throughout the country, 47 states and Puerto Rico experienced this in the week ended February 2.

Patients with chronic obstructive pulmonary disease (COPD) who receive a flu vaccine are significantly less likely to be hospitalized with influenza.

A look at last week's top stories in the world of pharmacy.

The newly FDA-approved drug blocks viral replication and RNA transcription via a cap-dependent endonuclease inhibitor.

Pharmacists are encouraged to discuss vaccination and prevention options with patients.

Top news of the day across the health care landscape.

Four cases address respiratory illnesses.

The guidelines recommend using molecular tests that deliver results in 15-60 minutes instead of rapid-influenza diagnostic tests (RIDTs), which produce quick results but can be falsely negative in at least 30% of outpatients with influenza.